FRFabiola Mabel Del Razo-Olvera

Fabiola Mabel Del Razo-Olvera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fabiola Mabel Del Razo-Olvera has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genotype and visceral adiposity interactions on hepatic steatosis in Mexican adults

    by Wendolyn E Dávila-Olmedo, Ana T Arias-Marroquín, Fabiola M Del Razo-Olvera, Paloma Almeda-Valdes, Ivette Cruz Bautista, Donaji V Gómez-Velasco, César E Lam-Chung, Alejandro Campos Muñóz, Berenice Rivera-Paredez, Paola Vázquez-Cárdenas, et al.

    Background: The SLC16A11 haplotype has been associated with type 2 diabetes (T2D) in populations with high Native American ancestry; however, its role in hepatic outcomes remains uncertain. We evaluated the association of rs13342232 with noninvasive liver markers and whether visceral adiposity tissue (VAT) modifies this relationship in Mexican adults with and without T2D. Methods: We included 607 adults (non-T2D, n = 256; T2D, n = 351) with genotype, VAT, and fatty liver index (FLI) data. Hepatic steatosis was additionally assessed using FibroScan-derived controlled attenuation parameter and steatosis grade in 301 participants. Multivariable regression models with VAT × rs13342232 interaction terms were fitted, adjusting for ancestry principal components. Results: A significant VAT × G/G interaction on FLI was observed in the full sample (β = 3.19, 95% CI 0.23-6.15; P = .035). The interaction was markedly stronger in adults without T2D (β = 7.51, 95% CI 1.23-13.78; P = .018) than in those with T2D (β = 2.00, 95% CI −0.43 to 4.42; P = .105), suggesting that the gene–environment effect is most clearly expressed before diabetes onset. Null findings for both the A/G interaction and the dominant model in the non-T2D stratum support a recessive inheritance pattern. FibroScan validation confirmed a VAT × G/G interaction on steatosis grade in non-T2D participants (β = .50, 95% CI 0.01-0.99; P = .044). In the T2D stratum, a significant negative A/G × VAT interaction was observed (β = −1.63, P = .046), indicating heterozygote attenuation of the VAT–steatosis relationship. Conclusion: The SLC16A11 rs13342232 G/G genotype amplifies the hepatic steatosis response to visceral adiposity in Mexican adults. This effect is strongest prior to diabetes onset, supporting a gene–environment interaction in hepatic fat accumulation.

  • Zinc deficiency and sarcopenia define a metabolic frailty phenotype predicting hepatic encephalopathy and early mortality in cirrhosis

    by Osvely Méndez-Guerrero, Anaisa Carranza-Carrasco, Rodrigo Guerrero-Guerrero, Lilia Castillo-Martínez, Fabiola M. Del Razo-Olvera, Liliana Juárez-Martínez, Rodrigo Otero-Otero, Alma Estanes-Hernández, Patricia Clark, Carlos A. Aguilar-Salinas, et al.

    Cirrhosis is characterized by progressive metabolic vulnerability, yet early indicators of clinical decompensation remain limited. Zinc, a key cofactor in ammonia detoxification and protein metabolism, may reflect and contribute to metabolic frailty when deficient. We aimed to determine whether zinc deficiency and sarcopenia jointly define a metabolic frailty phenotype that predicts overt hepatic encephalopathy (OHE) and mortality in cirrhosis. In this 12-month prospective cohort, 109 adults with cirrhosis were followed to evaluate OHE incidence and survival. Serum zinc, dietary intake, and nutritional parameters were assessed at baseline and 3, 6, and 12 months. Sarcopenia was defined by dual-energy X-ray absorptiometry and handgrip strength. Logistic regression identified independent predictors of OHE, and Kaplan-Meier analysis evaluated survival. OHE occurred in 27.5% of patients and was associated with lower zinc levels (50.3 ± 13.2 vs. 62.8 ± 18.9 µg/dL; p = 0.002) and higher sarcopenia prevalence (53.3% vs. 16.5%; p = 0.001). Zinc deficiency was associated with increased OHE risk (OR 3.9; 95% CI 1.5-10.1; p = 0.005), while multivariable analysis identified sarcopenia, age, and Child-Pugh class as independent predictors. The coexistence of zinc deficiency and sarcopenia identified a subgroup with the highest 1-year mortality (log-rank p = 0.001). Zinc deficiency and sarcopenia were associated with adverse clinical outcomes in cirrhosis and may reflect a broader state of metabolic vulnerability. Their coexistence defines a metabolic frailty phenotype in cirrhosis, associated with reduced metabolic reserve, OHE, and poor survival. Recognition of this phenotype provides a framework for targeted nutritional and metabolic interventions aimed at restoring functional reserve.

  • Open Access

    Insulin resistance and metabolic health predict cardiorespiratory fitness: cohort study

    by Liliana Muñoz-Hernandez, Ana Leonor Rivera, Adrian Soto-Mota, Jesus Paez-Mayorga, Jesus Flores-Brito, Erick Resendiz-Carrillo, Guillermo Roa-Alvarez, Leticia Lopez-Carreola, Sebastian Zamora-Gutierrez, Perla Alpizar-Chacon, et al.

    Aims/aims: Decreased cardiorespiratory fitness (CRF) is an all-cause mortality predictor. Oxygen consumption at peak exercise (VO2max) during a cardiopulmonary exercise test (CPET) is the gold standard for its evaluation. Since cardiometabolic risk factors reduce CRF, we aimed to assess the cardiopulmonary and metabolic responses during CPET and evaluate their determinants. Methods and results: Subjects underwent incremental treadmill CPET and bioelectrical impedance analysis. Insulin sensitivity was estimated using the HOMA, QUICKI, and METS-IR indices. Multivariate regressions were used to evaluate determinants of VO2max. Nonlinearity was confirmed with an F-test between linear and polynomial models. Five hundred and three subjects were evaluated, 474 met maximum effort criteria, (64% females). Median age was 4(26–52); 41% had normal weight, 33% overweight, 26% obesity. Prevalence of insulin resistance ranged from 22% to 46%, depending on the equation used. VO2max was 29.8(24–36) and 36.6 (30.6–43.3) mL/kg/min for females and males. Body composition analysis revealed that a higher BMI exhibited strong biological collinearity with metrics associated with adiposity excess and was inversely associated with CRF. After adjusting for age, sex, BMI, and fat mass, insulin resistance evaluated by QUICKI explained up to 43% of VO2max variability and was inversely associated with CRF. Conclusion: In a cohort of individuals without established CVD, the main determinants of CRF were modifiable risk factors associated with excess adiposity and insulin resistance. The potential mechanisms underlying the reduction in CRF include decreased relative muscle mass and insulin resistance, which reduce muscle glucose uptake and O2 consumption during maximum effort, where anaerobic glycolysis plays a central role.


  • Open Access

    Arterial Stiffness and HbA1c: Association Mediated by Insulin Resistance in Hispanic Adults

    by Alexandro J. Martagón, Carlos A. Fermín-Martínez, Neftali Eduardo Antonio-Villa, Roopa Mehta, Paloma Almeda-Valdés, Arsenio Vargas-Vázquez, Liliana Muñoz-Hernández, Donají V. Gómez-Velasco, Daniel Elías-López, Gabriela A. Galán-Ramírez, et al.

    Arterial stiffness may be associated with glucose metabolism parameters, such as HbA1c, mainly via insulin resistance. We aimed to investigate the association between arterial stiffness and HbA1c and explore the mediator effect of insulin resistance. In this cross-sectional study, arterial stiffness (pulse-wave velocity; PWV), HbA1c, and insulin resistance (METS-IR) were determined in Hispanic adults. In addition to sex and age, various biochemical measurements (glucose, lipid profile, etc.) and adipose tissue (fat mass and visceral fat mass) were considered as potential confounding variables. A multivariate regression analysis shows that HbA1c is associated with PWV, even after adjusting for several confounding variables. Importantly, the results show that insulin resistance mediated 17.9% of the effect of HbA1c over PWV. In conclusion, HbA1c may be a potential resource for predicting arterial stiffness due to the influence of insulin resistance in Hispanic subjects.


  • Open Access

    Primary Barriers of Adherence to a Structured Nutritional Intervention in Patients with Dyslipidemia

    by Fabiola Mabel Del Razo-Olvera, Angélica J. Martin-Vences, Griselda X. Brito-Córdova, Daniel Elías-López, María Victoria Landa-Anell, Marco Antonio Melgarejo-Hernández, Ivette Cruz-Bautista, Iliana Manjarrez-Martínez, Donají Verónica Gómez-Velasco, Carlos Alberto Aguilar-Salinas

    Purpose: To describe the primary barriers to adequately adhering to a structured nutritional intervention. Patients and methods: A total of 106 participants diagnosed with dyslipidemia and without a medical nutrition therapeutic plan were included in this two-year study conducted at the INCMNSZ dyslipidemia clinic in Mexico City. All patients were treated with the same structured strategies, including three face-to-face visits and two telephone follow-up visits. Diet plan adherence was evaluated at each site visit through a 3-day or 24-h food recall. Results: Barriers to adhere to the nutritional intervention were: lack of time to prepare their meals (23%), eating outside the home (19%), unwillingness to change dietary patterns (14%), and lack of information about a correct diet for dyslipidemias (14%). All barriers decreased significantly at the end of the intervention. Female gender, current smoking, and following a plan of more than 1500 kcal (R2 = 0.18 and p-value = 0.004) were associated with good diet adherence. Participants showed good levels of adherence to total caloric intake at visit 2 and 3, reporting 104.7% and 95.4%, respectively. Adherence to macronutrient intake varied from 65.1% to 126%, with difficulties in adhering to recommended carbohydrate and fat consumption being more notable. Conclusion: The study findings confirm that a structured nutritional intervention is effective in reducing barriers and improving dietary adherence and metabolic control in patients with dyslipidemias. Health providers must identify barriers to adherence early on to design interventions that reduce these barriers and improve adherence.


  • Open Access

    A High Incidence of Metabolic Syndrome Traits in Mexicans Points at Obesity-Related Metabolic Dysfunction

    by Omar Yaxmehen Bello-Chavolla, Arsenio Vargas-Vázquez, Neftali Eduardo Antonio-Villa, Fabiola Mabel Del Razo-Olvera, Daniel Elías-López, Carlos A Aguilar-Salinas

    Introduction: Metabolic Syndrome (MS) is a construct relating to a series of metabolic dysfunctions attributable to insulin resistance and obesity. Here, we estimate the incidence of MS according to their individual components using a Mexican open-population cohort. Methods: We evaluated data of 6144 Mexicans amongst whom 3340 did not have MS either by IDF or ATP-III definitions using data from an open-population cohort. We estimated the incidence of MS and each of its traits after a median follow-up of 2.24 (IQR 2.05– 2.58) years and evaluated risk factors for MS incidence and each of its traits. We also explored individuals without any MS trait to evaluate trait and MS incidence after follow-up. Results: We observed a high incidence of MS-IDF (115.11 cases per 1000 person-years, 95% CI 107.76– 122.47), followed by MS-ATP-III (75.77 cases per 1000 person-years, 95% CI). The MS traits with the highest incidence were low HDL-C and abdominal obesity, which was consistent for subjects without MS and those without any MS trait. When assessing predictors of MS incidence, obesity, insulin resistance, and increased apolipoprotein B levels predicted MS incidence. Weight loss > 5% of body weight and physical activity were the main protective factors. Obesity was a main determinant for incident MS traits in our population, with weight loss being also a protective factor for most MS traits. Conclusion: We observed a high incidence of MS in apparently healthy Mexican adults. Low HDL-C and abdominal obesity were the most frequent incident MS traits, with obesity being the main determinant of its incidence.


  • Open Access

    Setting the Lipid Component of the Diet: A Work in Process

    by Fabiola M Del Razo Olvera, Marco A Melgarejo Hernández, Roopa Mehta, Carlos A Aguilar Salinas

    Some of the most relevant yet controversial issues in nutrition are those surrounding the guidelines on quality and quantity of dietary fat in the pr